S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|AstraZeneca's Brilinta Study Meets Primary Targets (2015/1/14)|
|UPDATE: AstraZeneca advances in London; pound rises as inflation ticks up (2014/11/18)|
|Broken Deals Rein In a Strong M&A Market (2015/1/1)|
|QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies|
|U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes|
|AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting|
|AstraZeneca Announces Initiation of Development Program for BRILINTA (ticagrelor) Reversal Agent|
|Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment|
|PEGASUS-TIMI 54 Study of BRILINTA® Meets Primary Endpoint in Both 60mg and 90mg Doses|
|U.K. stocks fall after Japan GDP shock; AstraZeneca drops (2014/11/17)|
Click above to view more mutual fund data and stats for azn - AstraZeneca PLC ADR.